• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards.

作者信息

Geleziunas R, McQuillan A, Malapetsa A, Hutchinson M, Kopriva D, Wainberg M A, Hiscott J, Bramson J, Panasci L

机构信息

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.

出版信息

J Natl Cancer Inst. 1991 Apr 17;83(8):557-64. doi: 10.1093/jnci/83.8.557.

DOI:10.1093/jnci/83.8.557
PMID:2005641
Abstract

Resistance to the nitrogen mustards in patients with chronic lymphocytic leukemia (CLL) correlates with an enhanced removal of melphalan-induced DNA interstrand cross-links. This finding suggests that DNA repair enzymes may be involved in this process. The activity of 3-methyladenine-DNA glycosylase, which can release altered bases, including adducts at the N-7 position of guanine, was increased significantly in lymphocytes from patients with resistant CLL compared with those from untreated CLL patients. Since glycosylase activity varies with cell proliferation, the amount of [3H]thymidine incorporated into DNA was determined and found to be elevated almost threefold in lymphocytes from patients with resistant CLL. The ratio of glycosylase activity to level of thymidine incorporation did not differ between these two groups of patients. Northern blot analysis of ERCC1 gene (a putative DNA repair enzyme involved in nucleotide excision repair) expression in lymphocytes from patients with CLL revealed multiple gene transcripts (1.1, 3.4, and 3.8 kilobases). In addition, analysis of two samples revealed the presence of a 2.6-kilobase transcript. The 2.6-kilobase transcript was recognized by specific RNA probes that hybridize to antisense ERCC1 transcripts. Levels of expression of the 1.1-kilobase protein encoding transcript in lymphocytes from patients with resistant CLL were increased twofold to threefold above those of untreated patients with CLL. These results indicate that increased expression of ERCC1 and increased activity of 3-methyladenine-DNA glycosylase occur with the development of resistance to the nitrogen mustards in patients with CLL, suggesting a role for enhanced DNA repair in this process.

摘要

相似文献

1
Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards.
J Natl Cancer Inst. 1991 Apr 17;83(8):557-64. doi: 10.1093/jnci/83.8.557.
2
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.氮芥耐药B细胞慢性淋巴细胞白血病作为交联剂耐药的体内模型。
Mutat Res. 1995 May;336(3):269-78. doi: 10.1016/0921-8777(94)00063-c.
3
DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance.
Cancer Lett. 1995 Apr 14;90(2):139-48. doi: 10.1016/0304-3835(95)03696-t.
4
DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.DNA依赖性蛋白激酶活性与慢性淋巴细胞白血病淋巴细胞对氮芥的临床及体外敏感性相关。
Blood. 1998 Oct 1;92(7):2213-9.
5
Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links.
Biochem Pharmacol. 1989 Sep 15;38(18):3122-3. doi: 10.1016/0006-2952(89)90025-7.
6
Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).人B淋巴细胞系中的烷化剂抗性:(1). 美法仑敏感的B淋巴细胞系(WIL2)和美法仑抗性的B - CLL细胞系(WSU - CLL)中的美法仑蓄积、细胞毒性、链间DNA交联、细胞周期分析及谷胱甘肽含量。
Anticancer Res. 2000 Jul-Aug;20(4):2561-8.
7
Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.人B淋巴细胞系中的烷化剂抗性:(2). 美法仑抗性B-CLL细胞系中拓扑异构酶II表达水平及功能的增加
Anticancer Res. 2000 Jul-Aug;20(4):2569-78.
8
Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases.细菌和哺乳动物的3-甲基腺嘌呤-DNA糖基化酶对氮芥DNA加合物的切除作用
Carcinogenesis. 1996 Apr;17(4):643-8. doi: 10.1093/carcin/17.4.643.
9
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.氟达拉滨通过抑制链间DNA交联的去除,增加奥沙利铂对正常淋巴细胞和慢性淋巴细胞白血病淋巴细胞的细胞毒性。
Blood. 2006 Dec 15;108(13):4187-93. doi: 10.1182/blood-2006-05-023259. Epub 2006 Sep 5.
10
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.4-氢过氧环磷酰胺在慢性淋巴细胞白血病淋巴细胞中引发的DNA修复受到氟达拉滨和氯法拉滨的抑制。
Clin Cancer Res. 2001 Nov;7(11):3580-9.

引用本文的文献

1
Data-independent acquisition-based blood proteomics unveils predictive biomarkers for neonatal necrotizing enterocolitis.基于数据非依赖采集的血液蛋白质组学揭示了新生儿坏死性小肠结肠炎的预测生物标志物。
Anal Bioanal Chem. 2025 Jan;417(1):199-218. doi: 10.1007/s00216-024-05637-7. Epub 2024 Nov 20.
2
Leukemia cells are sensitized to temozolomide, carmustine and melphalan by the inhibition of O-methylguanine-DNA methyltransferase.通过抑制O-甲基鸟嘌呤-DNA甲基转移酶,白血病细胞对替莫唑胺、卡莫司汀和美法仑敏感。
Oncol Lett. 2015 Aug;10(2):845-849. doi: 10.3892/ol.2015.3307. Epub 2015 Jun 2.
3
Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.
鉴定基于20个基因表达的风险评分作为慢性淋巴细胞白血病患者临床结局的预测指标。
Biomed Res Int. 2014;2014:423174. doi: 10.1155/2014/423174. Epub 2014 May 5.
4
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.评估苯达莫司汀联合氟达拉滨治疗原发性慢性淋巴细胞白血病细胞。
Blood. 2014 Jun 12;123(24):3780-9. doi: 10.1182/blood-2013-12-541433. Epub 2014 Apr 18.
5
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.ROS 介导的 Noxa 上调克服慢性淋巴细胞白血病的化疗耐药性。
Oncogene. 2011 Feb 10;30(6):701-13. doi: 10.1038/onc.2010.441. Epub 2010 Oct 11.
6
Drug resistance and DNA repair in leukaemia.白血病的耐药性和 DNA 修复。
Cytotechnology. 1998 Sep;27(1-3):175-85. doi: 10.1023/A:1008064804678.
7
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.一项针对难治性急性白血病成人患者的,先使用氯法拉滨后使用环磷酰胺的1期临床实验室研究。
Blood. 2007 Sep 15;110(6):1762-9. doi: 10.1182/blood-2007-03-081364. Epub 2007 Jun 11.
8
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.氟达拉滨通过抑制链间DNA交联的去除,增加奥沙利铂对正常淋巴细胞和慢性淋巴细胞白血病淋巴细胞的细胞毒性。
Blood. 2006 Dec 15;108(13):4187-93. doi: 10.1182/blood-2006-05-023259. Epub 2006 Sep 5.
9
Alkylator-induced DNA excision repair in human leukemia CCRF-CEM cells in vitro, measured using the single-cell gel electrophoresis (comet) assay.使用单细胞凝胶电泳(彗星)试验测量体外人白血病CCRF-CEM细胞中烷化剂诱导的DNA切除修复。
Int J Hematol. 2002 Nov;76(4):328-32. doi: 10.1007/BF02982691.
10
Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.通过碱性单细胞凝胶电泳(彗星)试验测定氟达拉滨在体外对正常淋巴细胞中核苷酸切除修复的抑制作用。
Jpn J Cancer Res. 2002 May;93(5):567-73. doi: 10.1111/j.1349-7006.2002.tb01292.x.